Novartis advances head-to-head superiority trials of Cosentyx ® versus Humira®* and proposed biosimilar adalimumab**
Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS). SURPASS is the first head-to-head clinical trial in AS investigating superiority of Cosentyx in slowing spinal bone damage versus proposed biosimilar adalimumab**. SURPASS is currently recruiting patients, with the 'first patient first visit' already achieved in November 2017. (Source: World Pharma News)
Source: World Pharma News - January 9, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
Anti-IL17 Benefits Persist in Spine Disease (CME/CE)
(MedPage Today) -- Rapid responses seen for secukinumab in ankylosing spondylitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 27, 2017 Category: Primary Care Source Type: news
Juliette and Kirran explain what working on our campaign has meant to them
Arthritis Research UK’sThe Nation’s Joint Problem campaign has reached millions of people over the last three months, through national news stories and features and TV, cinema and billboard advertising. We asked two people who helped to shape the campaign content about their experience of being part of our ground-breaking push to change attitudes to arthritis.JulietteJournalist and author ofMostly Cloudy, Some Bright Spells Juliette Wills, 45, has lived with inflammatory spinal arthritis for 18 years. She wrote thesix powerful stories featured in The Guardian which exposed the hidden impact of arthritis, as wel...
Source: Arthritis Research UK - November 24, 2017 Category: Rheumatology Source Type: news
Patients' drugs fail to arrive at their homes
The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news
The patients left in despair as drugs fail to arrive
The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news
Golimumab Gets FDA Nod for Two New Indications Golimumab Gets FDA Nod for Two New Indications
The TNF-alpha inhibitor significantly improved the signs and symptoms of psoriatic arthritis and ankylosing spondylitis in phase 3 testing.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news
Janssen receives two u.s. fda approvals for simponi aria ® (golimumab)
for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved
for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news
FDA Approves Simponi Aria (golimumab) for the Treatment of Adults With Active Psoriatic Arthritis or Active Ankylosing Spondylitis
Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab), the only fully-human anti-tumor necrosis factor (TNF)-alpha therapy administered via a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news
Inflammatory Spinal Disorders Common in IBD Patients Inflammatory Spinal Disorders Common in IBD Patients
Ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and inflammatory back pain are common in inflammatory bowel disease (IBD) patients two decades after IBD diagnosis, according to findings from the IBSEN study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Ankylosing Spondylitis Quiz: Symptoms & Treatment
Title: Ankylosing Spondylitis Quiz: Symptoms& TreatmentCategory: MedicineNet QuizCreated: 1/16/2013 12:00:00 AMLast Editorial Review: 9/20/2017 1:05:25 PM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 20, 2017 Category: Rheumatology Source Type: news
Tofacitinib in Patients With Ankylosing Spondylitis Tofacitinib in Patients With Ankylosing Spondylitis
How do different doses of tofacitinib compare in terms of safety and efficacy?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
What Are the Side Effects of Prednisone for Ankylosing Spondylitis?
Title: What Are the Side Effects of Prednisone for Ankylosing Spondylitis?Category: Doctor's& Expert's views on SymptomsCreated: 8/29/2017 12:00:00 AMLast Editorial Review: 8/29/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 29, 2017 Category: Rheumatology Source Type: news
Back pain and fatigue? Symptoms could be warning sign of THIS form of arthritis
ARTHRITIS - inflammation of the joints - and back pain, are symptoms of long term chronic condition Ankylosing spondylitis . (Source: Daily Express - Health)
Source: Daily Express - Health - August 21, 2017 Category: Consumer Health News Source Type: news
